EphB receptor activity suppresses colorectal cancer progression.
Eduard E Batlle,
Julinor J Bacani,
Harry H Begthel,
Suzanne S Jonkheer,
Suzanne S Jonkeer,
Alexander A Gregorieff,
Maaike M van de Born,
Núria N Malats,
Elena E Sancho,
Elles E Boon,
Tony T Pawson,
Steven S Gallinger,
Steven S Pals and
Hans H Clevers
crossref 435(7045):1126-30 23 Jun 2005
PMID 15973414
Most sporadic colorectal cancers are initiated by activating Wnt pathway mutations, characterized by the stabilization of beta-catenin and constitutive transcription by the beta-catenin/T cell factor-4 (Tcf-4) complex. EphB guidance receptors are Tcf4 target genes that control intestinal epithelial architecture through repulsive interactions with Ephrin-B ligands. Here we show that, although Wnt signalling remains constitutively active, most human colorectal cancers lose expression of EphB at the adenoma-carcinoma transition. Loss of EphB expression strongly correlates with degree of malignancy. Furthermore, reduction of EphB activity accelerates tumorigenesis in the colon and rectum of Apc(Min/+) mice, and results in the formation of aggressive adenocarcinomas. Our data demonstrate that loss of EphB expression represents a critical step in colorectal cancer progression.
DOI: 10.1038/nature03626
Version: za2963e q8zad q8zb3 q8zcf q8zdb q8ze8 q8zf2 q8zga
Viewers of this paper also looked at these papers: